These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 15641881

  • 21. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L, Oepen G.
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [Abstract] [Full Text] [Related]

  • 22. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study.
    Berardi D, Amore M, Keck PE, Troia M, Dell'Atti M.
    Biol Psychiatry; 1998 Oct 15; 44(8):748-54. PubMed ID: 9798079
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report].
    Terlikowska M, Marzański M.
    Psychiatr Pol; 1995 Oct 15; 29(3):343-8. PubMed ID: 7652087
    [Abstract] [Full Text] [Related]

  • 25. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A, Lesch KP.
    Fortschr Neurol Psychiatr; 1997 Jan 15; 65(1):8-15. PubMed ID: 9132369
    [Abstract] [Full Text] [Related]

  • 26. Clinical risk factors for neuroleptic malignant syndrome.
    Berardi D, Dell'Atti M, Amore M, De Ronchi D, Ferrari G.
    Hum Psychopharmacol; 2002 Mar 15; 17(2):99-102. PubMed ID: 12404699
    [Abstract] [Full Text] [Related]

  • 27. Catatonia and NMS.
    Tan TK, Ong SH.
    Br J Psychiatry; 1991 Jun 15; 158():858-9. PubMed ID: 1678667
    [No Abstract] [Full Text] [Related]

  • 28. Risk factors for neuroleptic malignant syndrome.
    Francis A, Chandragiri S, Petrides G.
    Am J Psychiatry; 1998 Nov 15; 155(11):1639-40. PubMed ID: 9812151
    [No Abstract] [Full Text] [Related]

  • 29. Catatonia revived: a unique syndrome updated.
    Mormando C, Francis A.
    Int Rev Psychiatry; 2020 Nov 15; 32(5-6):403-411. PubMed ID: 32067538
    [Abstract] [Full Text] [Related]

  • 30. Neuroleptic malignant syndrome.
    Longhurst JG.
    Br J Psychiatry; 1995 Apr 15; 166(4):537-8. PubMed ID: 7795930
    [No Abstract] [Full Text] [Related]

  • 31. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
    Komatsu T, Nomura T, Takami H, Sakamoto S, Mizuno K, Sekii H, Hatta K, Sugita M.
    Intern Med; 2016 Apr 15; 55(19):2893-2897. PubMed ID: 27725556
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW.
    J Clin Psychopharmacol; 2010 Feb 15; 30(1):3-10. PubMed ID: 20075641
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Partially Treated Catatonia and Incipient Neuroleptic Malignant Syndrome: A Challenging Presentation.
    Mahgoub Y, Uy R, Hartman J.
    Prim Care Companion CNS Disord; 2020 Oct 08; 22(5):. PubMed ID: 33031648
    [No Abstract] [Full Text] [Related]

  • 39. Catatonia, neuroleptics and brain damage--a case report.
    Chandran M, El-Shazly M.
    J Psychopharmacol; 2009 Mar 08; 23(2):223-6. PubMed ID: 18562406
    [Abstract] [Full Text] [Related]

  • 40. Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series.
    Ghaziuddin N, Hendriks M, Patel P, Wachtel LE, Dhossche DM.
    J Child Adolesc Psychopharmacol; 2017 May 08; 27(4):359-365. PubMed ID: 28398818
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.